2012 Thoracic Symposium: HSP90 Inhibitor AT13387 Effective in Mutant EGFR and ALK-Positive NSCLC25 February 2012/in 2012, Onalespib (AT13387) – HSP90 inhibitor, Products2012 Thoracic Symposium: HSP90 Inhibitor AT13387 Effective in Mutant EGFR and ALK-Positive NSCLC https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2012-02-25 15:25:142016-11-25 15:28:182012 Thoracic Symposium: HSP90 Inhibitor AT13387 Effective in Mutant EGFR and ALK-Positive NSCLC
